Clinical Trial

Efficacy of Two Nasal Products Based on Diluted Seawater in the Treatment of Upper Respiratory Infections/Conditions

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated August 2, 2024 (before its estimated March 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this interventional clinical trial is to test the safety and efficacy of two medical devices in subjects aged from 3 months old for the treatment of colds, rhinitis, sinusitis, and other upper respiratory infections/conditions for 7 days.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06498843
Lead Sponsor YSLab
Conditions Rhinitis, Sinusitis, Upper Respiratory Infections, Colds
Enrollment 91 participants
Start Date 2025-01
Primary Completion 2025-03 (estimated)
Study Completion 2025-06 (estimated)
Updated on ClinicalTrials.gov 2024-08-02